Hangzhou Tigermed Consulting Co., Ltd.
Hangzhou Tigermed Consulting Co., Ltd.
Share · CNE100001KV8 (XSHE)
Overview
No Price
Closing Price XSHE 22.10.2025: 53,22 CNY
22.10.2025 07:04
1 day
-
1 week
-
1 month
-
3 months
-
6 months
-
Year to date
-
1 year
-
2 years
-
3 years
-
4 years
-
5 years
-
10 years
-
20 years
-
Max
-
Current Prices from Hangzhou Tigermed Consulting Co., Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XSHE: SHENZHEN STOCK EXCHANGE
SHENZHEN STOCK EXCHANGE
300347.SZ
CNY
22.10.2025 07:04
53,22 CNY
-0,48 CNY
-0,89 %
Share Float & Liquidity
Free Float 81,35 %
Shares Float 600,27 M
Shares Outstanding 737,9 M
Invested Funds

The following funds have invested in Hangzhou Tigermed Consulting Co., Ltd.:

Fund
iShares MSCI China UCITS ETF USD (Dist)
Vol. in million
0,69
Percentage (%)
0,02 %
Fund
iShares MSCI EM ESG Enhanced UCITS ETF USD (Dist)
Vol. in million
40,02
Percentage (%)
0,01 %
Fund
iShares MSCI EM ESG Enhanced UCITS ETF USD (Acc)
Vol. in million
168,53
Percentage (%)
0,01 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
72,09
Percentage (%)
0,0046 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
14,24
Percentage (%)
0,0046 %
Company Profile for Hangzhou Tigermed Consulting Co., Ltd. Share
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

Company Data

Name Hangzhou Tigermed Consulting Co., Ltd.
Company Hangzhou Tigermed Consulting Co., Ltd.
Website https://www.tigermed.net
Primary Exchange XSHE SHENZHEN STOCK EXCHANGE
ISIN CNE100001KV8
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Xiaoping Ye D.Phil, EMBA,
Market Capitalization 52 Mrd.
Country China
Currency CNY
Employees 10,2 T
Address F18, Building A – Shengda Science Park, 310051 Hangzhou
IPO Date 2012-08-17

Ticker Symbols

Name Symbol
SHENZHEN STOCK EXCHANGE 300347.SZ
More Shares
Investors who hold Hangzhou Tigermed Consulting Co., Ltd. also have the following shares in their portfolio:
LB.HESS.THR.CARRARA01D/22
LB.HESS.THR.CARRARA01D/22 Bond
WICKET GAMING AB
WICKET GAMING AB Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025